# Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: A Concluded Living Systematic Review and Meta-Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-tyrosine-kinase-inhibitors-in-renal-cell-carcinoma-a-concluded-living/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Irbaz Bin Riaz,Rabbia Siddiqi,Mahnoor Islam,Huan He,Anum Riaz,Noureen Asghar,Syed Arsalan Ahmed Naqvi,Jeremy L. Warner,M. Hassan Murad,Manish Kohli |
| Citations | 9 |
| DOI | 10.1200/cci.21.00035 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3164690039 |
| PMID | 34043431 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Noureen Asghar](https://scholariq.org/researchers/noureen-asghar/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.